Chemical, biological, and pharmacological data mining and annotation for the entire drug development cycle.
Preclinical and Clinical Data:
Reports examining chemical and biological data, as well as experimental data outcomes gathered from patents and journals, to better understand the mechanism of action at the molecular level.
Detailed investigation of epigenetic regulation, genotype-phenotype connection, and gene signatures linked to disease/treatment responses.
Coverage of significant disease areas and industry trends, as well as topical reports.
Target Analysis:
Track new molecular targets entering pipelines and in-and-out licencing activity around your chosen medicine or company with this target analysis.
Drug Reports:
Detailed information on the drug’s development history, licencing information, molecular structures, biological activity, safety, corporate development trends, worldwide development status, and therapeutic class status.
To find cooperation prospects, keep an eye on medicine and delivery advancements.
Biomarkers Reports:
Reports on interpreted biomarkers for disease association, molecular classification, prognostic, predictive, pharmacological target, and treatments are available in Biomarker Reports.
Raw gene expression files from the GEO database were analysed to provide a report on transcriptional biomarkers that represent a variety of human illness states and patient outcomes.
Medical Device:
Gives you a comprehensive picture of medical devices, diagnostics, and innovative delivery systems, allowing you to analyse the competition, track significant events, and make more educated decisions.
System Biology:
Information on genes, proteins, molecular processes, relationships, signal transduction networks, and other aspects of system biology is used to better understand disease mechanisms and therapeutic responses.
